Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis

Journal of Medical Microbiology

Volumn 57, Issue 12, 2008, Pages 1539-1546

  Choy, Man H ^a,b   Stapleton, Fiona ^a,b   Willcox, Mark D P ^a,b   Zhu, Hua ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b VISION COOPERATIVE RESEARCH CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BACTERIAL TOXIN; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; MOXIFLOXACIN; NETILMICIN; NORFLOXACIN; OFLOXACIN; PIPERACILLIN; PROTEINASE; TICARCILLIN; TOBRAMYCIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRALIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOFILM; COMPARATIVE STUDY; CONTACT LENS; CONTROLLED STUDY; GENOTYPE; KERATITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEROTYPE; STRAIN DIFFERENCE;

ADP RIBOSE TRANSFERASES; ANTI-BACTERIAL AGENTS; AUSTRALIA; BACTERIAL PROTEINS; BACTERIAL TOXINS; BIOFILMS; CONTACT LENSES; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; KERATITIS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEROTYPING; VIRULENCE FACTORS;

EID: 57749207267     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.2008/003723-0     Document Type: Article

References (68)

1. Andrews, J. M. (2007). BSAC standardized disc susceptibility testing method (version 6). J Antimicrob Chemother 60, 20-41.
2. Augustin, D. K., Song, Y., Baek, M. S., Sawa, Y., Singh, G., Taylor, B., Rubio-Mills, A., Flanagan, J. L., Wiener-Kronish, J. P. & Lynch, S. V. (2007). Presence or absence of lipopolysaccharide O antigens affects type III secretion by Pseudomonas aeruginosa. J Bacteriol 189, 2203-2209.
3. Bell, S., Gatus, B., Pham, J. & Rafferty, D. (2006). Antibiotic Susceptibility Testing by the CDS Method. A Manual for Medical and Veterinary Laboratories. Sydney: Arthur Productions.
4. Berthelot, P., Attree, I., Plesiat, P., Chabert, J., de Bentzmann, S., Pozzetto, B. & Grattard, F. (2003). Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes. J Infect Dis 188, 512-518.
5. Beveridge, T. J., Makin, S. A., Kadurugamuwa, J. L. & Li, Z. (1997). Interactions between biofilms and the environment. FEMS Microbiol Rev 20, 291-303.
6. Bourcier, T., Thomas, F., Borderie, V., Chaumeil, C. & Laroche, L. (2003). Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol 87, 834-838.
7. Cheng, K. H., Leung, S. L., Hoekman, H. W., Beekhuis, W. H., Mulder, P. G., Geerards, A. J. & Kijlstra, A. (1999). Incidence of contact-lens-associated microbial keratitis and its related morbidity. Lancet 354, 181-185 (see comment).
8. CLSI (2007). Performance Standards for Antimicrobial Susceptibility Testing, 17th informational supplement, M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute.
9. Costerton, J. W., Stewart, P. S. & Greenberg, E. P. (1999). Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-1322.
10. Cowell, B. A., Twining, S. S., Hobden, J. A., Kwong, M. S. F. & Fleiszig, S. M. J. (2003a). Mutation of lasA and lasB reduces Pseudomonas aeruginosa invasion of epithelial cells. Microbiology 149, 2291-2299.
11. Cowell, B. A., Weissman, B. A., Yeung, K. K., Johnson, L., Ho, S., Van, R., Bruckner, D., Mondino, B. & Fleiszig, S. M. J. (2003b). Phenotype of Pseudomonas aeruginosa isolates causing corneal infection between 1997 and 2000. Cornea 22, 131-134.
12. del Pozo, J. L. & Patel, R. (2007). The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther 82, 204-209.
13. Engel, L. S., Hill, J. M., Moreau, J. M., Green, L. C., Hobden, J. A. & O'Callaghan, R. J. (1998). Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Invest Ophthalmol Vis Sci 39, 662-665.
14. Faure, K., Shimabukuro, D., Ajayi, T., Allmond, L. R., Sawa, T. & Wiener-Kronish, J. P. (2003). O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa. J Clin Microbiol 41, 2158-2160.
15. Feltman, H., Schulert, G., Khan, S., Jain, M., Peterson, L. & Hauser, A. R. (2001). Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 147, 2659-2669.
16. Fleiszig, S. M., Wiener-Kronish, J. P., Miyazaki, H., Vallas, V., Mostov, K. E., Kanada, D., Sawa, T., Yen, T. S. & Frank, D. W. (1997). Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun 65, 579-586.
17. Fleiszig, S. M., Lee, E. J., Wu, C., Andika, R. C., Vallas, V., Portoles, M. & Frank, D. W. (1998). Cytotoxic strains of Pseudomonas aeruginosa can damage the intact corneal surface in vitro. CLAO J 24, 41-47.
18. Frank, D. W. (1997). The exoenzyme S regulon of Pseudomonas aeruginosa. Mol Microbiol 26, 621-629.
19. Galentine, P. G., Cohen, E. J., Laibson, P. R., Adams, C. P., Michaud, R. & Arentsen, J. J. (1984). Corneal ulcers associated with contact lens wear. Arch Ophthalmol 102, 891-894.
20. Goodman, A. L., Lory, S., Goodman, A. L. & Lory, S. (2004). Analysis of regulatory networks in Pseudomonas aeruginosa by genomewide transcriptional profiling. Curr Opin Microbiol 7, 39-44.
21. Green, M. D., Apel, A. J., Naduvilath, T. & Stapleton, F. J. (2007). Clinical outcomes of keratitis. Clin Experiment Ophthalmol 35, 421-426.
22. Green, M., Apel, A. & Stapleton, F. (2008a). A longitudinal study of trends in keratitis in Australia. Cornea 27, 33-39.
23. Green, M., Apel, A. & Stapleton, F. (2008b). Risk factors and causative organisms in microbial keratitis. Cornea 27, 22-27.
24. Hauser, A. R., Cobb, E., Bodi, M., Mariscal, D., Valles, J., Engel, J. N. & Rello, J. (2002). Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 30, 521-528.
25. Hobden, J. A. (2002). Pseudomonas aeruginosa proteases and corneal virulence. DNA Cell Biol 21, 391-396.
26. Hooi, S. H. & Hooi, S. T. (2005). Culture-proven bacterial keratitis in a Malaysian general hospital. Med J Malaysia 60, 614-623.
27. Hwang, D. G. (2004). Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol 49 (Suppl. 2), S79-S83.
28. Imayasu, M., Shiraishi, A., Ohashi, Y., Shimada, S. & Cavanagh, H. D. (2008). Effects of multipurpose solutions on corneal epithelial tight junctions. Eye Contact Lens 34, 50-55.
29. Jain, M., Ramirez, D., Seshadri, R., Cullina, J. F., Powers, C. A., Schulert, G. S., Bar-Meir, M., Sullivan, C. L., McColley, S. A. & Hauser, A. R. (2004). Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis. J Clin Microbiol 42, 5229-5237.
30. Keay, L., Edwards, K., Naduvilath, T., Forde, K. & Stapleton, F. (2006). Factors affecting the morbidity of contact lens-related microbial keratitis: a population study. Invest Ophthalmol Vis Sci 47, 4302-4308.
31. Kowalski, R. P., Pandya, A. N., Karenchak, L. M., Romanowski, E. G., Husted, R. C., Ritterband, D. C., Shah, M. K. & Gordon, Y. J. (2001). An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa. Ophthalmology 108, 1826-1829.
32. Kowalski, R. P., Dhaliwal, D. K., Karenchak, L. M., Romanowski, E. G., Mah, F. S., Ritterband, D. C. & Gordon, Y. J. (2003). Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 136, 500-505.
33. Kunimoto, D. Y., Sharma, S., Garg, P. & Rao, G. N. (1999). In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin: emerging resistance. Ophthalmology 106, 80-85.
34. Lakkis, C. & Fleiszig, S. M. (2001). Resistance of Pseudomonas aeruginosa isolates to hydrogel contact lens disinfection correlates with cytotoxic activity. J Clin Microbiol 39, 1477-1486.
35. Lau, G. W., Hassett, D. J., Britigan, B. E., Lau, G. W., Hassett, D. J. & Britigan, B. E. (2005). Modulation of lung epithelial functions by Pseudomonas aeruginosa. Trends Microbiol 13, 389-397.
36. Lee, V. T., Smith, R. S., Tummler, B. & Lory, S. (2005). Activities of Pseudomonas aeruginosa effectors secreted by the type III secretion system in vitro and during infection. Infect Immun 73, 1695-1705.
37. Leibowitz, H. M. (1991). Clinical evaluation of ciprofloxacin 0.3 % ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol 112, 34S-47S.
38. Liesegang, T. J. (1997). Contact lens-related microbial keratitis: part I: epidemiology. Cornea 16, 125-131.
39. Lomholt, J. A., Poulsen, K. & Kilian, M. (2001). Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors. Infect Immun 69, 6284-6295.
40. McLaughlin-Borlace, L., Stapleton, F., Matheson, M. & Dart, J. K. (1998). Bacterial biofilm on contact lenses and lens storage cases in wearers with microbial keratitis. J Appl Microbiol 84, 827-838.
41. O'Brien, T. P., Maguire, M. G., Fink, N. E., Alfonso, E. & McDonnell, P. (1995). Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. Arch Ophthalmol 113, 1257-1265.
42. O'Toole, G. A. & Kolter, R. (1998). Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 28, 449-461.
43. Parmar, P., Salman, A., Kalavathy, C. M., Kaliamurthy, J., Thomas, P. A. & Jesudasan, C. A. (2006). Microbial keratitis at extremes of age. Cornea 25, 153-158.
44. Pinna, A., Usai, D., Sechi, L. A., Molicotti, P., Zanetti, S. & Carta, A. (2008). Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers. Cornea 27, 320-326.
45. Priebe, G. P., Dean, C. R., Zaidi, T., Meluleni, G. J., Coleman, F. T., Coutinho, Y. S., Noto, M. J., Urban, T. A., Pier, G. B. & Goldberg, J. B. (2004). The galU gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung. Infect Immun 72, 4224-4232.
46. Rossolini, G. M. & Mantengoli, E. (2005). Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 11 (Suppl. 4), 17-32.
47. Rumbaugh, K. P., Griswold, J. A. & Hamood, A. N. (1999). Pseudomonas aeruginosa strains obtained from patients with tracheal, urinary tract and wound infection: variations in virulence factors and virulence genes. J Hosp Infect 43, 211-218.
48. Sadikot, R. T., Blackwell, T. S., Christman, J. W. & Prince, A. S. (2005). Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 171, 1209-1223.
49. Schein, O. D., Ormerod, L. D., Barraquer, E., Alfonso, E., Egan, K. M., Paton, B. G. & Kenyon, K. R. (1989). Microbiology of contact lens-related keratitis. Cornea 8, 281-285.
50. Sharma, N., Sinha, R., Singhvi, A. & Tandon, R. (2006). Pseudomonas keratitis after laser in situ keratomileusis. J Cataract Refract Surg 32, 519-521.
51. Smitha, S., Lalitha, P., Prajna, V. & Srinivasan, M. (2005). Susceptibility trends of Pseudomonas species from corneal ulcers. Indian J Med Microbiol 23, 168-171.
52. Stapleton, F., Keay, L., Jalbert, I. & Cole, N. (2007). The epidemiology of contact lens related infiltrates. Optom Vis Sci 84, 257-272.
53. Stepanovic, S., Vukovic, D., Dakic, I., Savic, B. & Svabic-Vlahovic, M. (2000). A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 40, 175-179.
54. Stepanovic, S., Vukovic, D., Hola, V., Bonaventura, G. D., Djukic, S., Cirkovic, I. & Ruzicka, F. (2007). Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115, 891-899.
55. Thibodeaux, B. A., Caballero, A. R., Marquart, M. E., Tommassen, J. & O'Callaghan, R. J. (2007). Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida. Curr Eye Res 32, 373-386.
56. Thuruthyil, S. J., Zhu, H. & Willcox, M. D. (2001). Serotype and adhesion of Pseudomonas aeruginosa isolated from contact lens wearers. Clin Experiment Ophthalmol 29, 147-149.
57. Tingpej, P., Smith, L., Rose, B., Zhu, H., Conibear, T., Al Nassafi, K., Manos, J., Elkins, M., Bye, P. & other authors (2007). Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis. J Clin Microbiol 45, 1697-1704.
58. Wareham, D. W. & Curtis, M. A. (2007). A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates. Int J Med Microbiol 297, 227-234.
59. Wilhelmus, K. R., Hyndiuk, R. A., Caldwell, D. R., Abshire, R. L., Folkens, A. T. & Godio, L. B. (1993). 0.3 % ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment/Bacterial Keratitis Study Group. Arch Ophthalmol 111, 1210-1218.
60. Willcox, M. D. (2006). Which is more important to the initiation of contact lens related microbial keratitis, trauma to the ocular surface or bacterial pathogenic factors? Clin Exp Optom 89, 277-279.
61. Willcox, M. D. (2007). Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. Optom Vis Sci 84, 273-278.
62. Willcox, M. D., Zhu, H., Conibear, T. C., Hume, E. B., Givskov, M., Kjelleberg, S. & Rice, S. A. (2008). Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis. Microbiology 154, 2184-2194.
63. Wong-Beringer, A., Wiener-Kronish, J., Lynch, S. & Flanagan, J. (2008). Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 14, 330-336.
64. Yahr, T. L. & Wolfgang, M. C. (2006). Transcriptional regulation of the Pseudomonas aeruginosa type III secretion system. Mol Microbiol 62, 631-640.
65. Zaborina, O., Kohler, J. E., Wang, Y., Bethel, C., Shevchenko, O., Wu, L., Turner, J. R. & Alverdy, J. C. (2006). Identification of multidrug resistant Pseudomonas aeruginosa clinical isolates that are highly disruptive to the intestinal epithelial barrier. Ann Clin Microbiol Antimicrob 5, 14.
66. Zegans, M. E., Becker, H. I., Budzik, J. & O'Toole, G. (2002). The role of bacterial biofilms in ocular infections. DNA Cell Biol 21, 415-420.
67. Zhu, H., Thuruthyil, S. J. & Willcox, M. D. (2002). Determination of quorum-sensing signal molecules and virulence factors of Pseudomonas aeruginosa isolates from contact lens-induced microbial keratitis. J Med Microbiol 51, 1063-1070.
68. Zhu, H., Conibear, T. C. R., Bandara, R., Aliwarga, Y., Stapleton, F. & Willcox, M. D. P. (2006). Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis. Curr Eye Res 31, 297-306.